HIF1A and benign neoplasm: We observed that the frequency of nuclear expression of HIF-1α in benign tumours was lower than in borderline and ovarian cancer tumours, which is in agreement with previous findings [6,7,10] and supports the assertion that HIF-1α can be considered a hallmark of tumour progression in ovarian carcinomas.